U.S. federal trademark · Serial No. 78802680
Pharmaceutical preparations for treating viral infections caused by a virus having a polymerase gene conserved in the pyrophosphate binding site, namely HIV (human immunodeficiency virus), HSV (herpes simplex virus), CMV (cytomegalovirus), HPV (human papilloma virus), West Nile Virus, and Influenza Virus, including Influenza Virus Type A
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.